This study reveals that COL1A2 drives the transition from non-muscle-invasive to muscle-invasive bladder cancer via a spatially resolved ECM-FAK signaling axis, delineated through single-cell transcriptomics. Here, PTK2 is linked to urinary bladder carcinoma.